Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience

Sergio Palmeri; Carlo Putzu; Pasquale Comella; Gianfranco Filippelli; Enrico Barbato; Giovanni Condemi; Giuseppe Barberis; Giacomo Vessia; Salvatore Tafuto; Claudia Sandomenico; Maria Teresa Ionta; Bruno Massidda; Donato Natale

Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience

Sergio Palmeri, Carlo Putzu, Pasquale Comella, Gianfranco Filippelli, Enrico Barbato, Giovanni Condemi, Giuseppe Barberis, Giacomo Vessia, Salvatore Tafuto, Claudia Sandomenico, Maria Teresa Ionta, Bruno Massidda, Donato Natale

Discipline Chirurgiche, Oncologiche e Stomatologiche

Risultato della ricerca: Article

1 Citazioni (Scopus)

Lingua originale	English
pagine (da-a)	42-47
Numero di pagine	6
Rivista	Clinical Colorectal Cancer
Volume	10 (1)
Stato di pubblicazione	Published - 2011

All Science Journal Classification (ASJC) codes

Oncology
Gastroenterology

Accesso al documento

OA Link

Cita questo

Palmeri, S., Putzu, C., Comella, P., Filippelli, G., Barbato, E., Condemi, G., Barberis, G., Vessia, G., Tafuto, S., Sandomenico, C., Ionta, M. T., Massidda, B., & Natale, D. (2011). Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. Clinical Colorectal Cancer, 10 (1), 42-47.

Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. / Palmeri, Sergio; Putzu, Carlo; Comella, Pasquale; Filippelli, Gianfranco; Barbato, Enrico; Condemi, Giovanni; Barberis, Giuseppe; Vessia, Giacomo; Tafuto, Salvatore; Sandomenico, Claudia; Ionta, Maria Teresa; Massidda, Bruno; Natale, Donato.

In: Clinical Colorectal Cancer, Vol. 10 (1), 2011, pag. 42-47.

Risultato della ricerca: Article

Palmeri, S, Putzu, C, Comella, P, Filippelli, G, Barbato, E, Condemi, G, Barberis, G, Vessia, G, Tafuto, S, Sandomenico, C, Ionta, MT, Massidda, B & Natale, D 2011, 'Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience', Clinical Colorectal Cancer, vol. 10 (1), pagg. 42-47.

Palmeri, Sergio ; Putzu, Carlo ; Comella, Pasquale ; Filippelli, Gianfranco ; Barbato, Enrico ; Condemi, Giovanni ; Barberis, Giuseppe ; Vessia, Giacomo ; Tafuto, Salvatore ; Sandomenico, Claudia ; Ionta, Maria Teresa ; Massidda, Bruno ; Natale, Donato. / Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. In: Clinical Colorectal Cancer. 2011 ; Vol. 10 (1). pagg. 42-47.

@article{e597c7ab16eb42a3ab5d4d9ee5f200e9,

title = "Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience",

keywords = "BEVACIZUMAB, COLORECTAL CANCER, METASTATIC, BEVACIZUMAB, COLORECTAL CANCER, METASTATIC",

author = "Sergio Palmeri and Carlo Putzu and Pasquale Comella and Gianfranco Filippelli and Enrico Barbato and Giovanni Condemi and Giuseppe Barberis and Giacomo Vessia and Salvatore Tafuto and Claudia Sandomenico and Ionta, {Maria Teresa} and Bruno Massidda and Donato Natale",

year = "2011",

language = "English",

volume = "10 (1)",

pages = "42--47",

journal = "Clinical Colorectal Cancer",

issn = "1533-0028",

publisher = "Elsevier",

}

TY - JOUR

T1 - Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience

AU - Palmeri, Sergio

AU - Putzu, Carlo

AU - Comella, Pasquale

AU - Filippelli, Gianfranco

AU - Barbato, Enrico

AU - Condemi, Giovanni

AU - Barberis, Giuseppe

AU - Vessia, Giacomo

AU - Tafuto, Salvatore

AU - Sandomenico, Claudia

AU - Ionta, Maria Teresa

AU - Massidda, Bruno

AU - Natale, Donato

PY - 2011

Y1 - 2011

KW - BEVACIZUMAB

KW - COLORECTAL CANCER

KW - METASTATIC

KW - BEVACIZUMAB

KW - COLORECTAL CANCER

KW - METASTATIC

UR - http://hdl.handle.net/10447/59452

M3 - Article

VL - 10 (1)

SP - 42

EP - 47

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

ER -